Tuesday, December 06, 2022
Immunovia, the diagnostics company that has launched the world's first blood test dedicated to the early detection of pancreatic cancer, today announced that its U.S. subsidiary, Immunovia Inc., has appointed a new National Sales Director.
Jon Hager starts in his position today and has an extensive track record as a top-performing sales leader at companies like Ethos Labs, Myriad Genetics and Pfizer. He has earned multiple sales awards and promotions for his results and brings a wealth of experience growing new products, including at Myriad Genetics where he was a core member of the team that launched hereditary cancer testing to gynecologists.
"We are very pleased to welcome Jon to Immunovia. His ability to drive revenue growth combined with his passion for developing people make him a valuable addition to our sales team and U.S. organization", said Jeff Borcherding, CEO, Immunovia Inc., the U.S. subsidiary of Immunovia AB.
